Corcept Therapeutics | CORT - Cost Of Sales


Corcept Therapeutics reported $2.54M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 26.22M 4.58M Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
ANI Pharmaceuticals USD 116.02M 18.12M Sep/2025
Ardelyx USD 3.98M 10.84M Sep/2025
Assertio Holdings USD 8.89M 2.29M Jun/2024
Aurora Cannabis CAD 58.08M 11.99M Sep/2025
BioMarin Pharmaceutical USD 161.56M 16.62M Dec/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Canopy Growth CAD 44.78M 9.32M Sep/2025
Corcept Therapeutics USD 2.54M 2.05M Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
J&J USD 7.97B 689M Dec/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Lexicon Pharmaceuticals USD 17.81M 3.41M Jun/2024
Merck USD 3.32B 531M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Novartis USD 3.54B 217M Sep/2025
Novartis USD 3.54B 216M Sep/2025
Omeros USD 33.16M 18.52M Jun/2024
Pacira USD 54.62M 6.02M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Supernus Pharmaceuticals USD 47.53M 4.24M Dec/2025
TG Therapeutics USD 38.14M 10.05M Dec/2025